Updated Mar. 6, 2014 at 7:16 a.m.

Premium Lock RTP's Metabolon to help genome pioneer Craig Venter find ways to help us live longer

Published: 2014-03-06 07:09:00
Updated: 2014-03-06 07:16:17

Metabolon’s “Analytical Platform”: “Metabolon’s platform is designed and optimized to detect small molecule biomarkers from numerous chemical classes and various sample matrices (e.g. plasma, serum, urine, CSF, cell extracts, tissues). Analysis by three unique analytical platforms, shown below, separates and detects the broadest range of biochemicals.” Image 1 of 4 · Next Image…

Metabolon will utilize its proprietary molecular technology to help Human Longevity Inc., the new company led by genome pioneer Craig Venter, to find indications of disease and gene mutations....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2017 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders